187 related articles for article (PubMed ID: 14718800)
1. Neurotoxicity of taxanes: symptoms and quality of life assessment.
Kuroi K; Shimozuma K
Breast Cancer; 2004; 11(1):92-9. PubMed ID: 14718800
[TBL] [Abstract][Full Text] [Related]
2. Taxane induced neuropathy in patients affected by breast cancer: Literature review.
De Iuliis F; Taglieri L; Salerno G; Lanza R; Scarpa S
Crit Rev Oncol Hematol; 2015 Oct; 96(1):34-45. PubMed ID: 26004917
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of taxane neurotoxicity.
Hagiwara H; Sunada Y
Breast Cancer; 2004; 11(1):82-5. PubMed ID: 14718798
[TBL] [Abstract][Full Text] [Related]
4. [Expert consensus on standardized management of taxane-related peripheral neuropathy].
Taxane-related Peripheral Neuropathy Standardized Management Group
Zhonghua Zhong Liu Za Zhi; 2020 Mar; 42(3):170-179. PubMed ID: 32252195
[TBL] [Abstract][Full Text] [Related]
5. Techniques for the neurological examination of taxane-induced neuropathy.
Ohsumi S; Sunada Y
Breast Cancer; 2004; 11(1):86-91. PubMed ID: 14718799
[TBL] [Abstract][Full Text] [Related]
6. Taxane and epothilone-induced peripheral neurotoxicity: From pathogenesis to treatment.
Tamburin S; Park SB; Alberti P; Demichelis C; Schenone A; Argyriou AA
J Peripher Nerv Syst; 2019 Oct; 24 Suppl 2():S40-S51. PubMed ID: 31647157
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms underlying chemotherapy-induced neurotoxicity and the potential for neuroprotective strategies.
Park SB; Krishnan AV; Lin CS; Goldstein D; Friedlander M; Kiernan MC
Curr Med Chem; 2008; 15(29):3081-94. PubMed ID: 19075655
[TBL] [Abstract][Full Text] [Related]
8. Treatment and care of neurotoxicity from taxane anticancer agents.
Makino H
Breast Cancer; 2004; 11(1):100-4. PubMed ID: 14718801
[TBL] [Abstract][Full Text] [Related]
9. Taxane-induced polyneuropathy - current possibilities of prediction and management.
Jablonická M; Žideková L; Mladosievičová B
Vnitr Lek; 2021; 67(1):26-31. PubMed ID: 33752398
[TBL] [Abstract][Full Text] [Related]
10. Quality-of-life considerations with taxane-based therapy in metastatic breast cancer.
Maxwell C
Clin J Oncol Nurs; 2013 Feb; 17 Suppl():35-40. PubMed ID: 23360701
[TBL] [Abstract][Full Text] [Related]
11. Case report: painful peripheral neuropathy following treatment with docetaxel for breast cancer.
Wampler MA; Hamolsky D; Hamel K; Melisko M; Topp KS
Clin J Oncol Nurs; 2005 Apr; 9(2):189-93. PubMed ID: 15853162
[TBL] [Abstract][Full Text] [Related]
12. Assessing the impact of chemotherapy-induced peripheral neurotoxicity on the quality of life of cancer patients: the introduction of a new measure.
Driessen CM; de Kleine-Bolt KM; Vingerhoets AJ; Mols F; Vreugdenhil G
Support Care Cancer; 2012 Apr; 20(4):877-81. PubMed ID: 22160655
[TBL] [Abstract][Full Text] [Related]
13. Overview of neuropathy associated with taxanes for the treatment of metastatic breast cancer.
Rivera E; Cianfrocca M
Cancer Chemother Pharmacol; 2015 Apr; 75(4):659-70. PubMed ID: 25596818
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy-induced polyneuropathy: major agents and assessment by questionnaires.
Zedan AH; Vilholm OJ
Basic Clin Pharmacol Toxicol; 2014 Aug; 115(2):193-200. PubMed ID: 24796774
[TBL] [Abstract][Full Text] [Related]
15. Electrophysiological and phenotypic profiles of taxane-induced neuropathy.
Timmins HC; Li T; Huynh W; Kiernan MC; Baron-Hay S; Boyle F; Goldstein D; Park SB
Clin Neurophysiol; 2020 Aug; 131(8):1979-1985. PubMed ID: 32291143
[TBL] [Abstract][Full Text] [Related]
16. Peripheral nerve damage associated with administration of taxanes in patients with cancer.
Argyriou AA; Koltzenburg M; Polychronopoulos P; Papapetropoulos S; Kalofonos HP
Crit Rev Oncol Hematol; 2008 Jun; 66(3):218-28. PubMed ID: 18329278
[TBL] [Abstract][Full Text] [Related]
17. Risks and benefits of taxanes in breast and ovarian cancer.
Michaud LB; Valero V; Hortobagyi G
Drug Saf; 2000 Nov; 23(5):401-28. PubMed ID: 11085347
[TBL] [Abstract][Full Text] [Related]
18. Corticosteroid co-medication does not reduce the incidence and severity of neurotoxicity induced by docetaxel.
Pronk LC; Hilkens PH; van den Bent MJ; van Putten WL; Stoter G; Verweij J
Anticancer Drugs; 1998 Oct; 9(9):759-64. PubMed ID: 9840720
[TBL] [Abstract][Full Text] [Related]
19. Peripheral neurotoxicity induced by docetaxel.
Hilkens PH; Verweij J; Stoter G; Vecht CJ; van Putten WL; van den Bent MJ
Neurology; 1996 Jan; 46(1):104-8. PubMed ID: 8559354
[TBL] [Abstract][Full Text] [Related]
20. Electrophysiological features of taxane-induced polyneuropathy in patients with breast cancer.
Chen X; Stubblefield MD; Custodio CM; Hudis CA; Seidman AD; DeAngelis LM
J Clin Neurophysiol; 2013 Apr; 30(2):199-203. PubMed ID: 23545771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
